Equibles does not estimate personal net worth.
Get an email with a short summary when Ginkgo Bioworks Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get DNA alertsSteven Coen is recorded as CFO at Ginkgo Bioworks Holdings, Inc. (DNA). The newest filing on record that lists Steven Coen as CFO at Ginkgo Bioworks Holdings, Inc. (DNA) is dated April 29, 2026. The proxy statement of Ginkgo Bioworks Holdings, Inc. reports total compensation of $1,332,326 for Steven Coen in fiscal 2025, including a base salary of $433,692. Steven Coen has spoken on 3 earnings calls across 1 company, most recently for Ginkgo Bioworks Holdings, Inc. on November 5, 2026. Ginkgo Bioworks Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ginkgo Bioworks Holdings, Inc. includes Jason Kelly (CEO and Board Member), Reshma Shetty (COO and Board Member), Steven P. Coen (Chief Accounting Officer) and 7 others.
“Before I walk through our financials, I want to remind everyone that our biosecurity results are classified as discontinued operations within our financial statements.”
“Before I walk through our financials, I want to take a moment to frame an important change in how we are presenting our results beginning in Q1, 2026. As we announced in February, we entered into a definitive agreement to sell our biosecurity business, which was previously reported as a separate segment.”
“I'll start with the cell engineering business. Cell engineering revenue was $26 million in the fourth quarter of 2025, down 26% compared to the fourth quarter of 2024.”
Start not stated–present
Last confirmed April 29, 2026
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Ginkgo Bioworks Holdings, Inc. (DNA) | Chief Financial Officer | $433,692 | $1,332,326 |
